Rattanawong Pattara, Chao Chieh-Ju, Sriramoju Anil, Tagle-Cornell Cecilia, Farina Juan Maria M, Beirne Ellen, Girardo Marlene E, Koepke Laura M, Fatunde Olubadewa A, Ko Ko Nway L, Shen Win-Kuang
Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Mayo Clin Proc Innov Qual Outcomes. 2025 Apr 22;9(3):100620. doi: 10.1016/j.mayocpiqo.2025.100620. eCollection 2025 Jun.
To examine the association between syncope and all-cause mortality in a large cohort of patients with heart failure (HF) with syncope.
We retrospectively identified a cohort of patients with HF and syncope from January 1, 2010, to December 31, 2015, and matched them in a 1:1 propensity analysis with patients with HF without syncope. A multivariable Cox regression model was used to estimate the association between syncope and the end point, all-cause mortality.
During the study period, 3449 patients with HF were diagnosed with syncope (mean ± SD age, 72.8±14.3 years). At 12 months follow-up, syncope was not an independent risk factor of all-cause mortality in overall patients with HF (hazard ratio [HR], 0.98; 95% CI, 0.91-1.04; =.467), HF with preserved ejection fraction (EF) (HR, 1.02; 95% CI, 0.93-1.11; =.686), HF with mid-range EF (HR, 0.92; 95% CI, 0.73-1.16; =.494), or HF with reduced EF (HR, 0.94; 95% CI, 0.83-1.06; =284). In the subgroup of those with cardiac implantable electronic devices, syncope significantly increased the risk of all-cause mortality in HF with reduced EF (HR, 1.28; 95% CI, 1.01-1.62; =.038).
Syncope was not an independent risk of all-cause mortality for patients with HF but significantly predicted the all-cause mortality in the subgroup of patients with heart failure reduced EF with cardiac implantable electronic devices.
在一大群伴有晕厥的心力衰竭(HF)患者中,研究晕厥与全因死亡率之间的关联。
我们回顾性地确定了一组2010年1月1日至2015年12月31日期间患有HF和晕厥的患者,并在1:1倾向分析中将他们与无晕厥的HF患者进行匹配。使用多变量Cox回归模型来估计晕厥与终点全因死亡率之间的关联。
在研究期间,3449例HF患者被诊断为晕厥(平均±标准差年龄,72.8±14.3岁)。在12个月的随访中,晕厥并非所有HF患者全因死亡率的独立危险因素(风险比[HR],0.98;95%置信区间[CI],0.91 - 1.04;P = 0.467),也不是射血分数(EF)保留的HF患者(HR,1.02;95% CI,0.93 - 1.11;P = 0.686)、EF中等范围的HF患者(HR,0.92;95% CI,0.73 - 1.16;P = 0.494)或EF降低的HF患者(HR,0.94;95% CI,0.83 - 1.06;P = 0.284)全因死亡率的独立危险因素。在植入心脏植入式电子设备的亚组中,晕厥显著增加了EF降低的HF患者全因死亡风险(HR,1.28;95% CI,1.01 - 1.62;P = 0.038)。
晕厥并非HF患者全因死亡的独立危险因素,但在植入心脏植入式电子设备且EF降低的心力衰竭患者亚组中,显著预测了全因死亡率。